- Tytuł:
- Resistance to anti-PD-1/anti-PDL1: galectin-3 inhibition with GB1211 reverses galectin-3- induced blockade of pembrolizumab and atezolizumab binding to PD-1/PD-L1.
- Autorzy:
- Temat:
-
PROGRAMMED cell death 1 receptors
PROGRAMMED death-ligand 1
IMMUNE checkpoint proteins
ATEZOLIZUMAB
TUMOR-infiltrating immune cells
IPILIMUMAB - Źródło:
- Frontiers in Immunology; 2023, p1-11, 11p
Czasopismo naukowe